Transgenic mouse studies have shown that hyperactivation of the Wnt/β‐catenin pathway, e.g. in MMTV‐Wnt1 and MMTV‐ΔN89‐β‐catenin mice, causes the development of mammary tumors [21, 22]. The gene discussed is WNT1; the disease is breast cancer.